272 related articles for article (PubMed ID: 17519994)
1. [Secondary prophylaxis after ischemic stroke and transitoric ischemic attack].
Russell D; Lund C; Dahl A
Tidsskr Nor Laegeforen; 2007 May; 127(10):1379-82. PubMed ID: 17519994
[TBL] [Abstract][Full Text] [Related]
2. [Transitory ischemic attack].
Lund C; Dahl A; Russell D
Tidsskr Nor Laegeforen; 2007 Mar; 127(7):900-2. PubMed ID: 17435814
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic interventions for prevention of recurrent ischemic stroke.
Kirshner HS
Am J Manag Care; 2008 Jun; 14(6 Suppl 2):S212-26. PubMed ID: 18611103
[TBL] [Abstract][Full Text] [Related]
4. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
5. [Stroke--primary prophylaxis].
Russell D; Dahl A; Lund C
Tidsskr Nor Laegeforen; 2007 Mar; 127(6):754-8. PubMed ID: 17363990
[TBL] [Abstract][Full Text] [Related]
6. [Drug therapy in secondary prophylaxis after transient cerebral ischemia or cerebral infarction].
Salvesen R
Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2875-7. PubMed ID: 14600713
[TBL] [Abstract][Full Text] [Related]
7. Progress in secondary stroke prevention.
Romano JG; Sacco RL
Ann Neurol; 2008 Apr; 63(4):418-27. PubMed ID: 18438951
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of transient ischemic attack: an important component of stroke prevention.
Nguyen-Huynh MN; Johnston SC
Nat Clin Pract Cardiovasc Med; 2007 Jun; 4(6):310-8. PubMed ID: 17522720
[TBL] [Abstract][Full Text] [Related]
9. New guidelines for the prevention of recurrent stroke. Updated recommendations can help people who have had a stroke or TIA lessen their chances of another "brain attack".
Harv Heart Lett; 2014 Aug; 24(12):6. PubMed ID: 25230422
[No Abstract] [Full Text] [Related]
10. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.
Sacco RL; Adams R; Albers G; Alberts MJ; Benavente O; Furie K; Goldstein LB; Gorelick P; Halperin J; Harbaugh R; Johnston SC; Katzan I; Kelly-Hayes M; Kenton EJ; Marks M; Schwamm LH; Tomsick T; ; ;
Circulation; 2006 Mar; 113(10):e409-49. PubMed ID: 16534023
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study.
Hennerici MG;
Cerebrovasc Dis; 2009; 27 Suppl 3():28-32. PubMed ID: 19439938
[TBL] [Abstract][Full Text] [Related]
13. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines" program.
LaBresh KA; Reeves MJ; Frankel MR; Albright D; Schwamm LH
Arch Intern Med; 2008 Feb; 168(4):411-7. PubMed ID: 18299497
[TBL] [Abstract][Full Text] [Related]
14. Primary and secondary prevention of ischemic stroke.
Paciaroni M; Bogousslavsky J
Eur Neurol; 2010; 63(5):267-78. PubMed ID: 20357456
[TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
[TBL] [Abstract][Full Text] [Related]
16. The emergency department: first line of defense in preventing secondary stroke.
Ovbiagele B
Acad Emerg Med; 2006 Feb; 13(2):215-22. PubMed ID: 16436789
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
18. [A survey on cerebral infarction/transient ischemic attack inpatients compliance with secondary stroke prevention and follow-up 90 days].
Ma RH; Wang YJ; Wang CX; Zhao XQ; Wang YL; Xu MJ; Wei M; Li Y; Zhang Z; Zhang WW; Wang L; Lin L; Li HT; Zheng T; Wang XW; Li JJ; Lü Y; Qi D
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2618-22. PubMed ID: 19080709
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of treating hyperfibrinogenemia with intermittently administered batroxobin in patients with ischemic stroke/transient ischemic attack for secondary prevention.
Xu G; Liu X; Zhu W; Yin Q; Zhang R; Fan X
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):193-7. PubMed ID: 17287638
[TBL] [Abstract][Full Text] [Related]
20. Danshen extracts decrease blood C reactive protein and prevent ischemic stroke recurrence: a controlled pilot study.
Xu G; Zhao W; Zhou Z; Zhang R; Zhu W; Liu X
Phytother Res; 2009 Dec; 23(12):1721-5. PubMed ID: 19449344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
